Loading...
Encision Inc.
ECIA•PNK
Healthcare
Medical - Instruments & Supplies
$0.35
$0.00(0.00%)
Encision Inc. (ECIA) Financial Performance & Income Statement Overview
Review Encision Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
-10.38%
↓ 10.38%
Operating Income Growth
-111.48%
↓ 111.48%
Net Income Growth
-89.01%
↓ 89.01%
Operating Cash Flow Growth
116.77%
↑ 116.77%
Operating Margin
-8.52%
↓ 8.52%
Gross Margin
50.29%
↑ 50.29%
Net Profit Margin
-8.96%
↓ 8.96%
ROE
-32.89%
↓ 32.89%
ROIC
-24.63%
↓ 24.63%
Encision Inc. (ECIA) Income Statement & Financial Overview
Review Encision Inc.'s (ECIA) income statement with detailed quarterly and annual figures.
| Metric | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|
| Revenue | $1.59M | $1.76M | $1.63M | $1.52M |
| Cost of Revenue | $735291.00 | $926906.00 | $688268.00 | $879000.00 |
| Gross Profit | $850290.00 | $828482.00 | $942663.00 | $646000.00 |
| Gross Profit Ratio | $0.54 | $0.47 | $0.58 | $0.42 |
| R&D Expenses | $138804.00 | $155515.00 | $139180.00 | $222000.00 |
| SG&A Expenses | $732353.00 | $831885.00 | $775140.00 | $811378.00 |
| Operating Expenses | $871157.00 | $987400.00 | $914320.00 | $1.05M |
| Total Costs & Expenses | $1.61M | $1.91M | $1.60M | $1.93M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $9508.00 | $10598.00 | $6369.00 | $10225.00 |
| Depreciation & Amortization | $15330.00 | $23203.00 | $19322.00 | $20861.00 |
| EBITDA | $173.00 | -$136465.00 | $47735.00 | -$308671.00 |
| EBITDA Ratio | $0.00 | -$0.08 | $0.03 | -$0.20 |
| Operating Income | -$20867.00 | -$158918.00 | $28343.00 | -$402000.00 |
| Operating Income Ratio | -$0.01 | -$0.09 | $0.02 | -$0.26 |
| Other Income/Expenses (Net) | -$3801.00 | -$11344.00 | -$6302.00 | -$7000.00 |
| Income Before Tax | -$24668.00 | -$170262.00 | $22041.00 | -$409000.00 |
| Income Before Tax Ratio | -$0.02 | -$0.10 | $0.01 | -$0.27 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$24668.00 | -$170262.00 | $22041.00 | -$409000.00 |
| Net Income Ratio | -$0.02 | -$0.10 | $0.01 | -$0.27 |
| EPS | -$0.002 | -$0.01 | $0.002 | -$0.03 |
| Diluted EPS | -$0.002 | -$0.01 | $0.002 | -$0.03 |
| Weighted Avg Shares Outstanding | $11.88M | $11.88M | $11.88M | $11.77M |
| Weighted Avg Shares Outstanding (Diluted) | $11.88M | $11.88M | $11.91M | $11.77M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan